Does EVOLOCUMAB Cause Injection site reaction? 579 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 579 reports of Injection site reaction have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.4% of all adverse event reports for EVOLOCUMAB.
579
Reports of Injection site reaction with EVOLOCUMAB
0.4%
of all EVOLOCUMAB reports
6
Deaths
15
Hospitalizations
How Dangerous Is Injection site reaction From EVOLOCUMAB?
Of the 579 reports, 6 (1.0%) resulted in death, 15 (2.6%) required hospitalization.
Is Injection site reaction Listed in the Official Label?
Yes, Injection site reaction is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Injection site reaction?
ETANERCEPT (9,962)
ADALIMUMAB (4,375)
NALTREXONE (4,360)
DUPILUMAB (4,129)
GLATIRAMER (3,317)
IXEKIZUMAB (1,701)
METHOTREXATE (1,663)
TIRZEPATIDE (1,389)
TOCILIZUMAB (1,343)
CERTOLIZUMAB PEGOL (1,253)
Which EVOLOCUMAB Alternatives Have Lower Injection site reaction Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE